Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

FINASTERIDE AND TADALAFIL

FINASTERIDE; TADALAFIL

Standard Dose
5MG;5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FINASTERIDE AND TADALAFIL is listed in Drugs@FDA under application 218499 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FINASTERIDE; TADALAFIL Form and strength CAPSULE;ORAL - 5MG;5MG Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2025-03-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview FINASTERIDE AND TADALAFIL is listed in Drugs@FDA under application 218499 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FINASTERIDE; TADALAFIL Form and strength CAPSULE;ORAL - 5MG;5MG Sponsor NOVITIUM PHARMA Submission history Latest submission status date: 2025-03-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.